Peking University School of Oncology

Site:	Peking University School of Oncology
Address:
City:	Beijing
State:
Zip:	100142
Country:	China

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	A Study of Regorafenib Combined with Envafolimab for Metastatic Gastrointestinal Stromal Tumors with Kit Gene Exon 17 Mutation That Failed Standard Treatment	Recruiting	Active	Regorafenib + Envafolimab	NCT06772233
1	A Study of NB003 in Patients With Advanced Malignancies	Recruiting	Active	NB003	NCT04936178